(Q34341290)

1 August 2017

1 reference

title

Towards a molecular approach to gastric cancer management (English)

1 reference

1 August 2017

Boussioutas A

1

1 reference

PubMed ID

11512601

1 August 2017

Taupin D

series ordinal

2

1 reference

1 August 2017

1 July 2001

1 reference

Internal Medicine Journal

1 August 2017

1 reference

1 August 2017

31

1 reference

1 August 2017

5

1 reference

1 August 2017

296-303

1 reference

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

1 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Pathology of Gastric Carcinoma in Japanese Populations: Comparisons Between Miyagi Prefecture, Japan, and Hawaii 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

A case-control study of gastric cancer and diet in Italy: II. Association with nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Stomach cancer and food storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Electric refrigerator use and gastric cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Occupational risk factors for gastric cancer: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Cancer risk in the rubber industry: a review of the recent epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Molecular epidemiology, pathogenesis and prevention of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Expression genetics in cancer: shifting the focus from DNA to RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Tumor suppressor genes: the puzzle and the promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

E-cadherin germline mutations in familial gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

E-cadherin gene mutations in human gastric carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Use of a cDNA microarray to analyse gene expression patterns in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

The role of chemotherapy in the management of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Herceptin (trastuzamab) in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Sequence interpretation. Making sense of the sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Pieces of the puzzle: expressed sequence tags and the catalog of human genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

DNA microarray technology: the anticipated impact on the study of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Expression monitoring by hybridization to high-density oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Searching for evidence of altered gene expression: a comment on statistical analysis of microarray data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Functional discovery via a compendium of expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

The influence of the microenvironment on the malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Systematic variation in gene expression patterns in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Germline mutations of E-cadherin gene in Korean familial gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

Germline E-cadherin Gene (CDH1) Mutations Predispose to Familial Gastric Cancer and Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1445-5994.2001.00057.X

10.1046/J.1445-5994.2001.00057.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11512601